[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Codeine Drug Market Research Report 2023

December 2023 | 95 pages | ID: G3B41CC5A5C2EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

According to QYResearch’s new survey, global Codeine Drug market is projected to reach US$ 912.7 million in 2029, increasing from US$ 771.9 million in 2022, with the CAGR of 2.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Codeine Drug market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Codeine Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Taiji
  • Mallinckrodt
  • TEVA
  • Johnson & Johnson
  • Medreich
  • Sanofi Aventis
  • Cipla
  • Hikma
  • Pharmaceutical Associates
  • Novartis
  • Apotex
  • Viatris
  • Aristo Pharma GmbH
  • Lannett Company
  • Laboratoire Riva
Segment by Type
  • Single-ingredient Codeine
  • Multi-ingredient Medications Codeine
Segment by Application
  • Narcotic Analgesic
  • Antitussive
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The Codeine Drug report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Codeine Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Single-ingredient Codeine
  1.2.3 Multi-ingredient Medications Codeine
1.3 Market by Application
  1.3.1 Global Codeine Drug Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Narcotic Analgesic
  1.3.3 Antitussive
  1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Codeine Drug Market Perspective (2018-2029)
2.2 Codeine Drug Growth Trends by Region
  2.2.1 Global Codeine Drug Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Codeine Drug Historic Market Size by Region (2018-2023)
  2.2.3 Codeine Drug Forecasted Market Size by Region (2024-2029)
2.3 Codeine Drug Market Dynamics
  2.3.1 Codeine Drug Industry Trends
  2.3.2 Codeine Drug Market Drivers
  2.3.3 Codeine Drug Market Challenges
  2.3.4 Codeine Drug Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Codeine Drug Players by Revenue
  3.1.1 Global Top Codeine Drug Players by Revenue (2018-2023)
  3.1.2 Global Codeine Drug Revenue Market Share by Players (2018-2023)
3.2 Global Codeine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Codeine Drug Revenue
3.4 Global Codeine Drug Market Concentration Ratio
  3.4.1 Global Codeine Drug Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Codeine Drug Revenue in 2022
3.5 Codeine Drug Key Players Head office and Area Served
3.6 Key Players Codeine Drug Product Solution and Service
3.7 Date of Enter into Codeine Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CODEINE DRUG BREAKDOWN DATA BY TYPE

4.1 Global Codeine Drug Historic Market Size by Type (2018-2023)
4.2 Global Codeine Drug Forecasted Market Size by Type (2024-2029)

5 CODEINE DRUG BREAKDOWN DATA BY APPLICATION

5.1 Global Codeine Drug Historic Market Size by Application (2018-2023)
5.2 Global Codeine Drug Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Codeine Drug Market Size (2018-2029)
6.2 North America Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Codeine Drug Market Size by Country (2018-2023)
6.4 North America Codeine Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Codeine Drug Market Size (2018-2029)
7.2 Europe Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Codeine Drug Market Size by Country (2018-2023)
7.4 Europe Codeine Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Codeine Drug Market Size (2018-2029)
8.2 Asia-Pacific Codeine Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Codeine Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Codeine Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Codeine Drug Market Size (2018-2029)
9.2 Latin America Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Codeine Drug Market Size by Country (2018-2023)
9.4 Latin America Codeine Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Codeine Drug Market Size (2018-2029)
10.2 Middle East & Africa Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Codeine Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Codeine Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Taiji
  11.1.1 Taiji Company Detail
  11.1.2 Taiji Business Overview
  11.1.3 Taiji Codeine Drug Introduction
  11.1.4 Taiji Revenue in Codeine Drug Business (2018-2023)
  11.1.5 Taiji Recent Development
11.2 Mallinckrodt
  11.2.1 Mallinckrodt Company Detail
  11.2.2 Mallinckrodt Business Overview
  11.2.3 Mallinckrodt Codeine Drug Introduction
  11.2.4 Mallinckrodt Revenue in Codeine Drug Business (2018-2023)
  11.2.5 Mallinckrodt Recent Development
11.3 TEVA
  11.3.1 TEVA Company Detail
  11.3.2 TEVA Business Overview
  11.3.3 TEVA Codeine Drug Introduction
  11.3.4 TEVA Revenue in Codeine Drug Business (2018-2023)
  11.3.5 TEVA Recent Development
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Detail
  11.4.2 Johnson & Johnson Business Overview
  11.4.3 Johnson & Johnson Codeine Drug Introduction
  11.4.4 Johnson & Johnson Revenue in Codeine Drug Business (2018-2023)
  11.4.5 Johnson & Johnson Recent Development
11.5 Medreich
  11.5.1 Medreich Company Detail
  11.5.2 Medreich Business Overview
  11.5.3 Medreich Codeine Drug Introduction
  11.5.4 Medreich Revenue in Codeine Drug Business (2018-2023)
  11.5.5 Medreich Recent Development
11.6 Sanofi Aventis
  11.6.1 Sanofi Aventis Company Detail
  11.6.2 Sanofi Aventis Business Overview
  11.6.3 Sanofi Aventis Codeine Drug Introduction
  11.6.4 Sanofi Aventis Revenue in Codeine Drug Business (2018-2023)
  11.6.5 Sanofi Aventis Recent Development
11.7 Cipla
  11.7.1 Cipla Company Detail
  11.7.2 Cipla Business Overview
  11.7.3 Cipla Codeine Drug Introduction
  11.7.4 Cipla Revenue in Codeine Drug Business (2018-2023)
  11.7.5 Cipla Recent Development
11.8 Hikma
  11.8.1 Hikma Company Detail
  11.8.2 Hikma Business Overview
  11.8.3 Hikma Codeine Drug Introduction
  11.8.4 Hikma Revenue in Codeine Drug Business (2018-2023)
  11.8.5 Hikma Recent Development
11.9 Pharmaceutical Associates
  11.9.1 Pharmaceutical Associates Company Detail
  11.9.2 Pharmaceutical Associates Business Overview
  11.9.3 Pharmaceutical Associates Codeine Drug Introduction
  11.9.4 Pharmaceutical Associates Revenue in Codeine Drug Business (2018-2023)
  11.9.5 Pharmaceutical Associates Recent Development
11.10 Novartis
  11.10.1 Novartis Company Detail
  11.10.2 Novartis Business Overview
  11.10.3 Novartis Codeine Drug Introduction
  11.10.4 Novartis Revenue in Codeine Drug Business (2018-2023)
  11.10.5 Novartis Recent Development
11.11 Apotex
  11.11.1 Apotex Company Detail
  11.11.2 Apotex Business Overview
  11.11.3 Apotex Codeine Drug Introduction
  11.11.4 Apotex Revenue in Codeine Drug Business (2018-2023)
  11.11.5 Apotex Recent Development
11.12 Viatris
  11.12.1 Viatris Company Detail
  11.12.2 Viatris Business Overview
  11.12.3 Viatris Codeine Drug Introduction
  11.12.4 Viatris Revenue in Codeine Drug Business (2018-2023)
  11.12.5 Viatris Recent Development
11.13 Aristo Pharma GmbH
  11.13.1 Aristo Pharma GmbH Company Detail
  11.13.2 Aristo Pharma GmbH Business Overview
  11.13.3 Aristo Pharma GmbH Codeine Drug Introduction
  11.13.4 Aristo Pharma GmbH Revenue in Codeine Drug Business (2018-2023)
  11.13.5 Aristo Pharma GmbH Recent Development
11.14 Lannett Company
  11.14.1 Lannett Company Company Detail
  11.14.2 Lannett Company Business Overview
  11.14.3 Lannett Company Codeine Drug Introduction
  11.14.4 Lannett Company Revenue in Codeine Drug Business (2018-2023)
  11.14.5 Lannett Company Recent Development
11.15 Laboratoire Riva
  11.15.1 Laboratoire Riva Company Detail
  11.15.2 Laboratoire Riva Business Overview
  11.15.3 Laboratoire Riva Codeine Drug Introduction
  11.15.4 Laboratoire Riva Revenue in Codeine Drug Business (2018-2023)
  11.15.5 Laboratoire Riva Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Codeine Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Single-ingredient Codeine
Table 3. Key Players of Multi-ingredient Medications Codeine
Table 4. Global Codeine Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Codeine Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Codeine Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Codeine Drug Market Share by Region (2018-2023)
Table 8. Global Codeine Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Codeine Drug Market Share by Region (2024-2029)
Table 10. Codeine Drug Market Trends
Table 11. Codeine Drug Market Drivers
Table 12. Codeine Drug Market Challenges
Table 13. Codeine Drug Market Restraints
Table 14. Global Codeine Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Codeine Drug Market Share by Players (2018-2023)
Table 16. Global Top Codeine Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine Drug as of 2022)
Table 17. Ranking of Global Top Codeine Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Codeine Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Codeine Drug Product Solution and Service
Table 21. Date of Enter into Codeine Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Codeine Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Codeine Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Codeine Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Codeine Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Codeine Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Codeine Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Codeine Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Codeine Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Codeine Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Codeine Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Codeine Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Codeine Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Codeine Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Codeine Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Codeine Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Codeine Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Codeine Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Codeine Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Codeine Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Codeine Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Codeine Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Codeine Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Codeine Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Taiji Company Detail
Table 47. Taiji Business Overview
Table 48. Taiji Codeine Drug Product
Table 49. Taiji Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 50. Taiji Recent Development
Table 51. Mallinckrodt Company Detail
Table 52. Mallinckrodt Business Overview
Table 53. Mallinckrodt Codeine Drug Product
Table 54. Mallinckrodt Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 55. Mallinckrodt Recent Development
Table 56. TEVA Company Detail
Table 57. TEVA Business Overview
Table 58. TEVA Codeine Drug Product
Table 59. TEVA Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 60. TEVA Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Codeine Drug Product
Table 64. Johnson & Johnson Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Medreich Company Detail
Table 67. Medreich Business Overview
Table 68. Medreich Codeine Drug Product
Table 69. Medreich Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 70. Medreich Recent Development
Table 71. Sanofi Aventis Company Detail
Table 72. Sanofi Aventis Business Overview
Table 73. Sanofi Aventis Codeine Drug Product
Table 74. Sanofi Aventis Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 75. Sanofi Aventis Recent Development
Table 76. Cipla Company Detail
Table 77. Cipla Business Overview
Table 78. Cipla Codeine Drug Product
Table 79. Cipla Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 80. Cipla Recent Development
Table 81. Hikma Company Detail
Table 82. Hikma Business Overview
Table 83. Hikma Codeine Drug Product
Table 84. Hikma Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 85. Hikma Recent Development
Table 86. Pharmaceutical Associates Company Detail
Table 87. Pharmaceutical Associates Business Overview
Table 88. Pharmaceutical Associates Codeine Drug Product
Table 89. Pharmaceutical Associates Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 90. Pharmaceutical Associates Recent Development
Table 91. Novartis Company Detail
Table 92. Novartis Business Overview
Table 93. Novartis Codeine Drug Product
Table 94. Novartis Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Apotex Company Detail
Table 97. Apotex Business Overview
Table 98. Apotex Codeine Drug Product
Table 99. Apotex Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 100. Apotex Recent Development
Table 101. Viatris Company Detail
Table 102. Viatris Business Overview
Table 103. Viatris Codeine Drug Product
Table 104. Viatris Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 105. Viatris Recent Development
Table 106. Aristo Pharma GmbH Company Detail
Table 107. Aristo Pharma GmbH Business Overview
Table 108. Aristo Pharma GmbH Codeine Drug Product
Table 109. Aristo Pharma GmbH Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 110. Aristo Pharma GmbH Recent Development
Table 111. Lannett Company Company Detail
Table 112. Lannett Company Business Overview
Table 113. Lannett Company Codeine Drug Product
Table 114. Lannett Company Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 115. Lannett Company Recent Development
Table 116. Laboratoire Riva Company Detail
Table 117. Laboratoire Riva Business Overview
Table 118. Laboratoire Riva Codeine Drug Product
Table 119. Laboratoire Riva Revenue in Codeine Drug Business (2018-2023) & (US$ Million)
Table 120. Laboratoire Riva Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Codeine Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Codeine Drug Market Share by Type: 2022 VS 2029
Figure 3. Single-ingredient Codeine Features
Figure 4. Multi-ingredient Medications Codeine Features
Figure 5. Global Codeine Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Codeine Drug Market Share by Application: 2022 VS 2029
Figure 7. Narcotic Analgesic Case Studies
Figure 8. Antitussive Case Studies
Figure 9. Others Case Studies
Figure 10. Codeine Drug Report Years Considered
Figure 11. Global Codeine Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Codeine Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Codeine Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Codeine Drug Market Share by Players in 2022
Figure 15. Global Top Codeine Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Codeine Drug Revenue in 2022
Figure 17. North America Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Codeine Drug Market Share by Country (2018-2029)
Figure 19. United States Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Codeine Drug Market Share by Country (2018-2029)
Figure 23. Germany Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Codeine Drug Market Share by Region (2018-2029)
Figure 31. China Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Codeine Drug Market Share by Country (2018-2029)
Figure 39. Mexico Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Codeine Drug Market Share by Country (2018-2029)
Figure 43. Turkey Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Codeine Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Taiji Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 46. Mallinckrodt Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 47. TEVA Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 49. Medreich Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 50. Sanofi Aventis Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 51. Cipla Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 52. Hikma Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 53. Pharmaceutical Associates Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 55. Apotex Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 56. Viatris Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 57. Aristo Pharma GmbH Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 58. Lannett Company Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 59. Laboratoire Riva Revenue Growth Rate in Codeine Drug Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed


More Publications